U.S. Mortgage Finance Stock News

If you have been wondering whether Mid-America Apartment Communities at around US$128 per share offers value or risk, this article focuses squarely on what the current price could mean for you. The stock has been under pressure, with returns declining 2.3% over the past week, 0.3% over the past month, 7.9% year to date and 13.9% over the past year, which can shift how investors think about both downside risk and future upside potential. Recent news coverage around Mid-America Apartment...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

If you are wondering whether Intuit at around US$353.76 is now priced attractively or still looks expensive, the starting point is understanding what the current valuation actually reflects. The stock has had a mixed run recently, with a gain of 10.6% over the past week, a decline of 11.3% over the past month, and it remains down 43.8% year to date and 53.4% over the past year. These sharp moves have put Intuit back on many watchlists, as investors reassess what they are willing to pay for...

If you are wondering whether Dell Technologies at US$465.96 is still reasonably priced or already stretched, the starting point is to understand how its current market value compares with its fundamentals. The stock has seen very sharp recent moves, with returns of 57.9% over the past week, 121.7% over the past month, 264.6% year to date and 337.7% over the past year, on top of a very large 3 year gain and an 8x return over 5 years. Recent headlines around Dell have centred on its role in...

TFS Financial Corporation (NasdaqGS:TFSL) has amended its bylaws to reduce the number of directors on its Board from twelve to eleven. The change will take effect on May 28, 2026, following the retirement of director Meredith S. Weil. TFS Financial, the holding company for Third Federal Savings and Loan, operates in the retail banking and mortgage lending space, where regulation, consumer credit trends, and deposit costs can influence outcomes over time. Board composition matters in this...

Some CoreWeave, Inc. ( NASDAQ:CRWV ) shareholders may be a little concerned to see that the Independent Director, Jack...

Insiders who bought US$176.4k worth of Sensus Healthcare, Inc.'s ( NASDAQ:SRTS ) stock at an average buy price of...

The investors in Snowflake Inc. 's ( NYSE:SNOW ) will be rubbing their hands together with glee today, after the share...

Investors may wish to note that an insider of Franklin Financial Services Corporation , Steven Butz, recently netted...

Anyone interested in Lakeland Financial Corporation ( NASDAQ:LKFN ) should probably be aware that the Independent...

Leadership change and why it matters for ZIM Integrated Shipping Services stock ZIM Integrated Shipping Services (ZIM) has drawn fresh attention after announcing that Dr. Chen Lichtenstein will take over as President and CEO on July 1, 2026, subject to shareholder approval. For investors, this marks a key leadership transition at a time when the company is dealing with recent quarterly losses and complex corporate developments, including a proposed merger that has met resistance from several...

The Morning Bull - US Market Morning Update Tuesday, Jun, 2 2026 US stock futures are pointing slightly higher this morning, with key contracts linked to the S&P 500 and Nasdaq 100 up around 0.2% as investors weigh signs of stronger global manufacturing against rising costs and higher bond yields. Across Europe and parts of Asia, factory scorecards like the Eurozone manufacturing PMI at 51.6 and India’s PMI at 55.0 show production growing, but input prices are climbing and supply chains...

Stoke Therapeutics recently reported past first-quarter results and business updates, highlighting four years of Phase 1/2a data for zorevunersen showing sustained cognitive, behavioral, and seizure improvements, with patients treated for more than five years and the therapy remaining generally well tolerated. The company also outlined a path toward late-stage development, targeting completion of enrollment in the Phase 3 EMPEROR trial by June 2026 to support mid-2027 data and a rolling US...

In May 2026, Olema Pharmaceuticals announced preliminary Phase 1 data showing its KAT6 inhibitor OP-3136 was generally well-tolerated with early signs of anti-tumor activity, and entered a clinical trial collaboration and supply agreement with Bayer to test OP-3136 plus NUBEQA in metastatic castration-resistant prostate cancer. The collaboration allows Olema to jointly own combination data with Bayer while retaining full global commercial and marketing rights to OP-3136, an unusual balance...

Recently, Ripple Effect Asset Management disclosed buying 438,720 additional units of XPLR Infrastructure, LP for about US$4.52 million, as XPLR reported US$435 million of adjusted EBITDA and reaffirmed its full-year outlook while taking a 49% stake in four battery storage projects with NextEra Energy Resources. The move into battery storage alongside reaffirmed guidance highlights XPLR Infrastructure’s growing emphasis on revenue-generating renewable assets within its broader infrastructure...

Why COPT Defense Properties (CDP) Just Caught Investor Attention COPT Defense Properties (CDP) raised its 2026 guidance after reporting strong first quarter results. The company highlighted solid leasing activity, high tenant retention, and sector-leading occupancy across its defense-focused real estate portfolio. See our latest analysis for COPT Defense Properties. Despite a small pullback in the latest session, COPT Defense Properties’ share price has gained 15.1% year to date and its 1...

In late May 2026, Infleqtion announced a major expansion of its UK quantum operations with a new Quantum Innovation Centre in Oxford, tripling its local research, manufacturing and systems integration footprint and deepening ties to the UK’s national quantum programs. The move, alongside recent advances in neutral-atom quantum computing and expanded UK defence and government work, underlines Infleqtion’s aim to build a full-stack quantum platform spanning computing, sensing and timing within...

In late May 2026, Box, Inc. reported first-quarter revenue of US$305.94 million and net income of US$17.73 million, and issued guidance calling for approximately 9% year-over-year revenue growth for both the second quarter of 2026 and the fiscal year ending January 31, 2027, while also updating investors on progress under its US$1.39 billion share repurchase program. Beyond the headline growth figures, Box highlighted that foreign exchange is expected to create meaningful headwinds for...

Why VSE (VSEC) is back on investors’ radar VSE (VSEC) heads into a busy June investor conference schedule, including the William Blair Growth Stock Conference on June 2. The company recently completed the Precision Aviation Group acquisition and its shares closed at US$180.32. See our latest analysis for VSE. The recent 4.9% 7 day share price gain and 5.5% 30 day share price return contrast with a 16.8% decline over 90 days. At the same time, the 1 year total shareholder return of 38.8% and...

Octave Intelligence (OCTV) has drawn fresh attention after a sharp 16.4% one day gain to a last close of US$20.02, even as the stock remains down 8.8% year to date. See our latest analysis for Octave Intelligence. The recent 16.4% one-day share price return contrasts with a 7-day share price return that declined 7.95% and a year-to-date share price return that is down 8.83%. This suggests that momentum may be trying to recover after a weaker spell. If you are weighing what else might fit your...

In May 2026, Bicara Therapeutics reported three-year follow-up data from its Phase 1/1b study of ficerafusp alfa plus pembrolizumab in first-line recurrent or metastatic HPV‑negative head and neck squamous cell carcinoma, showing deep and durable responses across multiple dose cohorts with a generally well-tolerated safety profile and no new safety signals. A particularly interesting finding was that the 1,500mg weekly cohort showed an estimated three-year overall survival rate roughly twice...

Kaplan Fox & Kilsheimer LLP launched an investigation into GoDaddy (NYSE:GDDY) over potential securities law violations. The review follows GoDaddy’s recent disclosure about its promotional pricing strategy for dotcom domains. The company reported higher-than-expected demand for discounted domains, which affected upfront bookings and near-term revenue. The investigation focuses on whether investors were adequately informed about the financial impact of this pricing approach. GoDaddy, best...

Vertex (VERX) has been drawing attention after a sharp 12.1% move over the past day, adding to gains of about 11.3% in the past week, which puts recent performance in focus. See our latest analysis for Vertex. Even after this 12.1% one day jump to a share price of $14.96 and an 11.3% 7 day share price return, the year to date share price return is still down 21.3%, while the 1 year total shareholder return has declined 62.5%. This points to short term momentum picking up after a tougher...

Science Applications International (SAIC) opened Q1 2027 with revenue of US$1.9 billion and basic EPS of US$2.63, alongside net income excluding extra items of US$115 million, setting a clear marker for its latest earnings season update. The company has seen quarterly revenue move from US$1.88 billion and basic EPS of US$1.43 in Q1 2026 to US$1.9 billion and basic EPS of US$2.63 in Q1 2027, while trailing 12 month EPS has shifted from US$7.19 to US$8.94 over the same reference points, giving...